These days, columnist Dagmar Munn is all about manipulating the algorithm of her brain to improve her outlook and turn down ...

Researchers in Germany say combining two blood biomarkers may make the diagnosis of ALS more accurate and help predict ...

Preclinical data showed imaging agent ACI-19626 can selectively bind to abnormal clumps of the TDP-43 protein, a hallmark of ...

For guest writer Nancy Muirhead, dealing with food and beverages has become unpleasant due to ALS. She's decided to get a PEG ...

The Packard Center and ALS United will fund a preclinical study investigating how abnormal TDP-43 protein contributes to ALS.

A trial in Italy that's testing Avextra’s cannabis-based medicine for ALS and other neurodegenerative diseases enrolled its ...

After my husband, Todd, was diagnosed with ALS, I was shattered and desperate to connect with others who might understand the pain I was feeling.

People with ALS in the U.S. spend over $47,000 for medical care in the year after diagnosis, more than 3.5 times the average Medicare user.

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that can be classified into different types based on factors like genetics, a patient’s family history, and the ...

SPG302 was well tolerated in a trial, with preliminary data supporting the idea the therapy might slow ALS progression.

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder in which worsening muscle weakness leads to movement problems and other symptoms such as trouble swallowing, speaking, and breathing ...